Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma

8 Jan 2021

Abstract excerpt

BACKGROUND: African American/Black adults have a disproportionate incidence of Alzheimer's disease (AD) and are underrepresented in biomarker discovery efforts. OBJECTIVE: This study aimed to identify potential diagnostic biomarkers for AD using a combination of proteomics and machine learning approaches in a cohort that included African American/Black adults. METHODS: We conducted a discovery-based plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33427747
DOI: 10.3233/jad-201318

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in PlasmaPMID 33427747Read ↗

Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's diseaseSemantic proximity Read ↗

Exposing the Brain Proteomic Signatures of Alzheimer’s Disease in Diverse Racial Groups: Leveraging Multiple Data Sets and Machine LearningSemantic proximity Read ↗

Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s diseaseSemantic proximity Read ↗

Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseSemantic proximity Read ↗

Large-scale Deep Proteomic Analysis in Alzheimer’s Disease Brain Regions Across Race and EthnicitySemantic proximity Read ↗

Bridging the Gap: Multi-Omics Profiling of Brain Tissue in Alzheimer’s Disease and Older Controls in Multi-Ethnic PopulationsSemantic proximity Read ↗

Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African AmericansSemantic proximity Read ↗

Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populationsSemantic proximity Read ↗

Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.Semantic proximity Read ↗

Cerebrospinal Fluid (CSF) Proteomic Signature in Preclinical and Clinical AD: Role of Adhesion Molecules.Semantic proximity Read ↗

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.Semantic proximity Read ↗

Serum proteins can successfully predict self-reported ethnicity: Implications for precision-medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.